Therapy Response Prediction in Patients with Metastatic Soft Tissue Sarcomas Using CT based Delta Radiomics

preprint OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

Abstract This retrospective study investigates whether computed tomography (CT)-based delta-radiomics can improve systemic treatment response prediction in patients with metastatic STS. Data from 71 patients with initially unresectable, high-grade, metastasized STS treated at Erasmus Medical Center between 2014 and 2020 were included. Radiomics features were extracted from up to five metastases, and delta-radiomics were computed as the relative difference in features between pre-treatment and follow-up scans. Therapy response was modeled using survival analysis, utilizing the time interval from metastasis diagnosis to death or latest follow-up. To predict response, we employed automated machine learning differentiating three input configurations: 1) The imaging model, based on 107 quantitative features; 2) a diameter-only model; and 3) a volume-only model. Models were evaluated using a repeated nested 5-fold cross-validation. The imaging model achieved a mean c-index of 0.68 (95% CI: 0.60–0.76) and a one-year cumulative dynamic area under the curve (cAUC) of 0.75 (95% CI: 0.55–0.95). Diameter- and volume-only models performed worse, with c-indices of 0.61 (95% CI: 0.51–0.70) and 0.65 (95% CI: 0.53–0.76), and cAUCs of 0.60 (95% CI: 0.35–0.85) and 0.63 (95% CI: 0.38–0.88), respectively. These findings suggest that CT-based delta-radiomics is valuable for predicting therapy response in metastatic STS, warranting potential optimization and validation in larger, multi-center studies before clinical adoption.
Full text 14,588 characters · extracted from preprint-html · click to expand
Therapy Response Prediction in Patients with Metastatic Soft Tissue Sarcomas Using CT based Delta Radiomics | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Therapy Response Prediction in Patients with Metastatic Soft Tissue Sarcomas Using CT based Delta Radiomics Frederik Hartmann, Christianne Jansma, Manon Verburg, David Hanff, and 8 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8259738/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract This retrospective study investigates whether computed tomography (CT)-based delta-radiomics can improve systemic treatment response prediction in patients with metastatic STS. Data from 71 patients with initially unresectable, high-grade, metastasized STS treated at Erasmus Medical Center between 2014 and 2020 were included. Radiomics features were extracted from up to five metastases, and delta-radiomics were computed as the relative difference in features between pre-treatment and follow-up scans. Therapy response was modeled using survival analysis, utilizing the time interval from metastasis diagnosis to death or latest follow-up. To predict response, we employed automated machine learning differentiating three input configurations: 1) The imaging model, based on 107 quantitative features; 2) a diameter-only model; and 3) a volume-only model. Models were evaluated using a repeated nested 5-fold cross-validation. The imaging model achieved a mean c-index of 0.68 (95% CI: 0.60–0.76) and a one-year cumulative dynamic area under the curve (cAUC) of 0.75 (95% CI: 0.55–0.95). Diameter- and volume-only models performed worse, with c-indices of 0.61 (95% CI: 0.51–0.70) and 0.65 (95% CI: 0.53–0.76), and cAUCs of 0.60 (95% CI: 0.35–0.85) and 0.63 (95% CI: 0.38–0.88), respectively. These findings suggest that CT-based delta-radiomics is valuable for predicting therapy response in metastatic STS, warranting potential optimization and validation in larger, multi-center studies before clinical adoption. radiomics machine learning soft tissue sarcomas metastasis therapy response prediction Full Text Additional Declarations No competing interests reported. Supplementary Files SupplementaryMaterialforTherapyResponsePredictioninPatientswithMetastaticSoftTissueSarcomasUsingCTbasedDeltaRadiomics.pdf Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8259738","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":558330211,"identity":"50ee824b-fdb0-4c9d-958a-bb0ba74864c1","order_by":0,"name":"Frederik Hartmann","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA60lEQVRIiWNgGAWjYBAC9gYeGJP5ALKEBU4tPAdAWhJATLYEZAkJYrTwGBCphYH34OfKH9vkzaV7Pj6uqKmLNjh/OvED4w58WviSJc8k3DbcOefsZsMzxw7nbriRu1mC8QxuLfZA90g2JNxmBKrcJtnAdgCohXcbA2MbPlt4jH8CtdhvuJHz/GfDv7rcDefPEtRiBrIlEaiFjbGxjTl3w4FcAlqYecwsG9JuJ2+4kWYs2dh3OHcmyC+J+LSw9xjfbLC5bbvhRvLDjw3f6nL7zp/d+OFjmw1OLQzMWEUTcGsYBaNgFIyCUUAEAAC//VfL6e1AhwAAAABJRU5ErkJggg==","orcid":"","institution":"University Medical Center Rotterdam","correspondingAuthor":true,"prefix":"","firstName":"Frederik","middleName":"","lastName":"Hartmann","suffix":""},{"id":558330213,"identity":"41f21d08-8d2c-4e92-afa5-f9d46e7e9e10","order_by":1,"name":"Christianne Jansma","email":"","orcid":"","institution":"University Medical Center Rotterdam","correspondingAuthor":false,"prefix":"","firstName":"Christianne","middleName":"","lastName":"Jansma","suffix":""},{"id":558330214,"identity":"51d58830-be25-4602-b976-b2364b73ae33","order_by":2,"name":"Manon Verburg","email":"","orcid":"","institution":"University Medical Center Rotterdam","correspondingAuthor":false,"prefix":"","firstName":"Manon","middleName":"","lastName":"Verburg","suffix":""},{"id":558330217,"identity":"40952120-86fd-470c-86c7-6602cb5bd445","order_by":3,"name":"David Hanff","email":"","orcid":"","institution":"University Medical Center Rotterdam","correspondingAuthor":false,"prefix":"","firstName":"David","middleName":"","lastName":"Hanff","suffix":""},{"id":558330218,"identity":"ad0d5947-3aa0-46ca-885d-730e881e047c","order_by":4,"name":"Wiro J. Niessen","email":"","orcid":"","institution":"University of Groningen","correspondingAuthor":false,"prefix":"","firstName":"Wiro","middleName":"J.","lastName":"Niessen","suffix":""},{"id":558330224,"identity":"4d2f5837-8bc0-426d-86b5-b07f678a2c7d","order_by":5,"name":"Geert J.L.H. van Leenders","email":"","orcid":"","institution":"University Medical Center Rotterdam","correspondingAuthor":false,"prefix":"","firstName":"Geert","middleName":"J.L.H. van","lastName":"Leenders","suffix":""},{"id":558330225,"identity":"9a40b266-6869-45fa-8a4f-413beeba376b","order_by":6,"name":"Cornelis Verhoef","email":"","orcid":"","institution":"University Medical Center Rotterdam","correspondingAuthor":false,"prefix":"","firstName":"Cornelis","middleName":"","lastName":"Verhoef","suffix":""},{"id":558330226,"identity":"2acc9a7d-1fc7-4aeb-9526-7920f1fcc7b8","order_by":7,"name":"Enrico Martin","email":"","orcid":"","institution":"University Medical Center Utrecht","correspondingAuthor":false,"prefix":"","firstName":"Enrico","middleName":"","lastName":"Martin","suffix":""},{"id":558330228,"identity":"ec317e92-5b21-42ce-a6af-69c11197436a","order_by":8,"name":"Stefan Klein","email":"","orcid":"","institution":"University Medical Center Rotterdam","correspondingAuthor":false,"prefix":"","firstName":"Stefan","middleName":"","lastName":"Klein","suffix":""},{"id":558330230,"identity":"4d80d02d-5e96-467f-9b2a-9df1ba2057e8","order_by":9,"name":"Dirk J. Grünhagen","email":"","orcid":"","institution":"University Medical Center Rotterdam","correspondingAuthor":false,"prefix":"","firstName":"Dirk","middleName":"J.","lastName":"Grünhagen","suffix":""},{"id":558330236,"identity":"779b45cb-e76f-4fba-96f0-70d2bda3899b","order_by":10,"name":"Martijn P.A. Starmans","email":"","orcid":"","institution":"University Medical Center Rotterdam","correspondingAuthor":false,"prefix":"","firstName":"Martijn","middleName":"P.A.","lastName":"Starmans","suffix":""},{"id":558330239,"identity":"4ec11abb-ca03-43be-8860-685adc816b2c","order_by":11,"name":"Douwe J. Spaanderman","email":"","orcid":"","institution":"University Medical Center Rotterdam","correspondingAuthor":false,"prefix":"","firstName":"Douwe","middleName":"J.","lastName":"Spaanderman","suffix":""}],"badges":[],"createdAt":"2025-12-02 11:08:38","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-8259738/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-8259738/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":97952116,"identity":"4de5b8af-18d9-48af-b744-5a64d7ea7dcc","added_by":"auto","created_at":"2025-12-11 07:19:54","extension":"json","order_by":0,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":12503,"visible":true,"origin":"","legend":"","description":"","filename":"e6aa889648074d6f8b47403000001b0b.json","url":"https://assets-eu.researchsquare.com/files/rs-8259738/v1/7850ef07b7952fcef5693c73.json"},{"id":99316741,"identity":"17ffd5ef-02d8-4dc9-b840-32740426aa49","added_by":"auto","created_at":"2025-12-31 16:29:07","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":619176,"visible":true,"origin":"","legend":"","description":"","filename":"TherapyResponsePredictioninPatientswithMetastaticSoftTissueSarcomasUsingCTbasedDeltaRadiomics.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8259738/v1_covered_7754aaa9-0ffd-4e1b-9fe9-0737a1fc56a6.pdf"},{"id":97952117,"identity":"e7791d40-9ffd-4d17-a6dd-933b11dd7238","added_by":"auto","created_at":"2025-12-11 07:19:54","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":395646,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryMaterialforTherapyResponsePredictioninPatientswithMetastaticSoftTissueSarcomasUsingCTbasedDeltaRadiomics.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8259738/v1/1ead4fcb623802f1d854c7a4.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Therapy Response Prediction in Patients with Metastatic Soft Tissue Sarcomas Using CT based Delta Radiomics","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"radiomics, machine learning, soft tissue sarcomas, metastasis, therapy response prediction","lastPublishedDoi":"10.21203/rs.3.rs-8259738/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8259738/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"This retrospective study investigates whether computed tomography (CT)-based delta-radiomics can improve systemic treatment response prediction in patients with metastatic STS. Data from 71 patients with initially unresectable, high-grade, metastasized STS treated at Erasmus Medical Center between 2014 and 2020 were included. Radiomics features were extracted from up to five metastases, and delta-radiomics were computed as the relative difference in features between pre-treatment and follow-up scans. Therapy response was modeled using survival analysis, utilizing the time interval from metastasis diagnosis to death or latest follow-up. To predict response, we employed automated machine learning differentiating three input configurations: 1) The imaging model, based on 107 quantitative features; 2) a diameter-only model; and 3) a volume-only model. Models were evaluated using a repeated nested 5-fold cross-validation. The imaging model achieved a mean c-index of 0.68 (95% CI: 0.60–0.76) and a one-year cumulative dynamic area under the curve (cAUC) of 0.75 (95% CI: 0.55–0.95). Diameter- and volume-only models performed worse, with c-indices of 0.61 (95% CI: 0.51–0.70) and 0.65 (95% CI: 0.53–0.76), and cAUCs of 0.60 (95% CI: 0.35–0.85) and 0.63 (95% CI: 0.38–0.88), respectively. These findings suggest that CT-based delta-radiomics is valuable for predicting therapy response in metastatic STS, warranting potential optimization and validation in larger, multi-center studies before clinical adoption.","manuscriptTitle":"Therapy Response Prediction in Patients with Metastatic Soft Tissue Sarcomas Using CT based Delta Radiomics","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-12-11 07:19:49","doi":"10.21203/rs.3.rs-8259738/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"8a23f031-6640-4c2b-a7e8-0af81a064b4f","owner":[],"postedDate":"December 11th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2025-12-30T00:08:39+00:00","versionOfRecord":[],"versionCreatedAt":"2025-12-11 07:19:49","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-8259738","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8259738","identity":"rs-8259738","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0